SCHEMBL3849955

SCHEMBL3849955

CNS(=O)(=O)c1ccc(-c2ncnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cc23)s1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KIT P10721 6/20 0.36
PDPK1 O15530 1/20 0.33
CYP1A2 P05177 3/20 0.32
CYP3A4 P08684 3/20 0.32
CYP2D6 P10635 3/20 0.32
CYP2C19 P33261 3/20 0.32
ALOX5AP P20292 3/20 0.32
FEN1 P39748 3/20 0.32
LMNA P02545 2/20 0.32
HPGD P15428 2/20 0.32
MAPK1 P28482 2/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
PIK3CA P42336 1/20 0.32
MTOR P42345 1/20 0.32
TSHR P16473 2/20 0.32
MEN1 O00255 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3854489 0.91 PTGS2 (0.35) KITPDPK1CYP1A2CYP3A4CYP2D6
SCHEMBL3846696 0.90 KIT (0.35) KITPDPK1CYP1A2CYP3A4CYP2D6
SCHEMBL3846935 0.90 KIT (0.34) KITPDPK1PIK3CAMTORPTGS2
SCHEMBL3854179 0.89 KIT (0.34) KITCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3850966 0.87 KIT (0.34) KITCYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL3848129 0.87 KIT (0.33) KITCYP3A4ALOX5APFEN1HPGD
SCHEMBL5854240 0.86 KIT (0.37) KITCYP3A4ALOX5APFEN1HPGD
SCHEMBL3847208 0.86 L3MBTL1 (0.35) KITPDPK1ALOX5APFEN1ALDH1A1
SCHEMBL3846511 0.86 ALOX5AP (0.36) KITPDPK1CYP1A2CYP3A4CYP2D6
SCHEMBL3848730 0.86 ALOX5AP (0.35) KITPDPK1ALOX5APFEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed